October 23, 2019
Alexion ends third quarter 2019 with 23% increase in total revenues
Alexion finished the third quarter 2019 with total revenues of $1,263.1 million, which represents a 23% increase over 3the same…
Pharmaceuticals, Biotechnology and Life Sciences
Alexion finished the third quarter 2019 with total revenues of $1,263.1 million, which represents a 23% increase over 3the same…
Vertex Pharmaceuticals got approval from the USFDA for Trikafta, for treating cystic fibrosis in patients older than 12
SOUTH SAN FRANCISCO–(BUSINESS WIRE)–Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Jonathan Lim,…
Moderna recieved second rare disease program to receive Fast Track designation with mRNA-3927, which uses the same proprietary LNP formulation as…
Disarm Therapeutics has presented at Neuroscience 2019 that its novel small molecule SARM1 inhibitors reproduce the axonal protection phenotype seen…
Progenity has named new Chief Commercial Officer, boosting its capacity in executive leadership team.
Phillips-Medisize has won a contract to produce first electronic-enabled combination drug delivery product, which is a post-phase 3 developement stage…
RALEIGH, N.C.–(BUSINESS WIRE)– SignalPath, a healthcare technology company reimagining the execution of clinical trials, announces the closing of their Series…
PRINCETON, N.J. & SAN DIEGO–(BUSINESS WIRE)–Sonnet BioTherapeutics Inc., a clinical stage biopharmaceutical developing innovative targeted biologic drugs, announced today that…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#AI— Systems Oncology, LLC (“SO”) and The Pritzker Organization, LLC (“TPO”) announced today that Pritzker Family Business Interests…